VC-backed ProNAi files for IPO
Vancouver-based ProNAi Therapeutics, a developer of nucleic acid therapeutics, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. The stock will list on the NASDAQ under the ticker symbol "DNAI." Jefferies LLC and BofA Merrill Lynch will serve as the lead underwriters. ProNAi’s backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.
15 June 2015•2 mins read
